The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $84.08

Today's change-0.16 -0.19%
Updated March 28 9:52 AM EDT. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $84.08

Today's change-0.16 -0.19%
Updated March 28 9:52 AM EDT. Delayed by at least 15 minutes.

Eli Lilly and Co crosses below 20-day moving average

Eli Lilly and Co is lower today, dropping (U.S.)$0.16 or 0.19% to (U.S.)$84.08 and crossing below its 20-day moving average. Over the last five days, shares have gained 0.42% and are currently 2.39% off of the 52-week high. Shares have outperformed the S&P 500 by 4.28% during the last year.

Key company metrics

  • Open(U.S.) $84.27
  • Previous close(U.S.) $84.24
  • High(U.S.) $84.55
  • Low(U.S.) $84.07
  • Bid / Ask(U.S.) $84.08 / (U.S.) $84.11
  • YTD % change+14.32%
  • Volume143,264
  • Average volume (10-day)3,613,219
  • Average volume (1-month)3,713,103
  • Average volume (3-month)5,387,362
  • 52-week range(U.S.) $64.18 to (U.S.) $86.14
  • Beta0.34
  • Trailing P/E32.61×
  • P/E 1 year forward20.54×
  • Forward PEG1.67×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.47%
  • Trailing EPS(U.S.) $2.58
Updated March 28 9:52 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue5,7615,1925,4054,865
Total other revenue--------
Total revenue5,7615,1925,4054,865
Gross profit4,2953,7913,9403,542
Total cost of revenue1,4661,4011,4651,323
Total operating expense4,8844,2484,4824,149
Selling / general / administrative1,7901,5651,6231,474
Research & development1,4511,2361,3361,221
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1784658131
Other operating expenses, total--------
Operating income876944923716
Interest income (expense), net non-operating-61-58-57-57
Gain (loss) on sale of assets--------
Other--------
Income before tax892971945567
Income after tax772778748440
Income tax, total120193197127
Net income772778748440
Total adjustments to net income--------
Net income before extra. items772778748440
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items772778748440
Inc. avail. to common incl. extra. items772778748440
Diluted net income772778748440
Dilution adjustment--------
Diluted weighted average shares1,0641,0611,0601,063
Diluted EPS excluding extraordinary itemsvalue per share0.730.730.710.41
Dividends per sharevalue per share0.510.510.510.51
Diluted normalized EPSvalue per share0.870.770.750.51